Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Calprotectin-Directed Humira® Maintenance Therapy (CADHUM)
Phase 3
Withdrawn
- Conditions
- Crohn's Disease
- Interventions
- First Posted Date
- 2012-08-28
- Last Posted Date
- 2017-05-24
- Lead Sponsor
- Peter Higgins
- Registration Number
- NCT01674413
- Locations
- 🇺🇸
University of Michigan Health System, Ann Arbor, Michigan, United States
News
No news found